Effects of the nicotinic acetylcholine receptor antagonist mecamylamine on the discriminative stimulus effects of cocaine in male rhesus monkeys
- PMID: 24548245
- PMCID: PMC4067453
- DOI: 10.1037/a0035274
Effects of the nicotinic acetylcholine receptor antagonist mecamylamine on the discriminative stimulus effects of cocaine in male rhesus monkeys
Abstract
Preclinical drug discrimination procedures have been useful in understanding the pharmacological mechanisms of the subjective-like effects of abused drugs. Converging lines of evidence from neurochemical and behavioral studies implicate a potential role of nicotinic acetylcholine (nACh) receptors in the abuse-related effects of cocaine. The aim of the present study was to determine the effects of the nACh receptor antagonist mecamylamine on the discriminative stimulus effects of cocaine in nonhuman primates. The effects of mecamylamine on the cocaine-like discriminative stimulus effects of nicotine were also examined. Male rhesus monkeys (n = 5) were trained to discriminate 0.32 mg/kg, IM cocaine from saline in a 2-key, food-reinforced discrimination procedure. Initially, potency and time course of cocaine-like discriminative stimulus effects were determined for nicotine and mecamylamine alone. Test sessions were then conducted examining the effects of mecamylamine on cocaine or the cocaine-like discriminative stimulus effects of nicotine. Curiously, mecamylamine produced partial cocaine-like discriminative stimulus effects. Mecamylamine did not significantly alter the discriminative stimulus effects of cocaine up to doses that significantly decreased rates of operant responding. Mecamylamine and nicotine combinations were not different than saline. These results confirm previous nonhuman primate studies of partial substitution with nicotine and extend these findings with mecamylamine. Furthermore, these results extend previous results in rats suggesting cocaine may have nACh receptor antagonist properties.
PsycINFO Database Record (c) 2014 APA, all rights reserved.
Conflict of interest statement
Figures
References
-
- Banks Matthew L, Blough Bruce E, Fennell Timothy R, Snyder Rodney W, Stevens Negus, S. Role of phenmetrazine as an active metabolite of phendimetrazine: Evidence from studies of drug discrimination and pharmacokinetics in rhesus monkeys. Drug Alcohol Depend. 2013;130(1–3):158–166. http://dx.doi.org/10.1016/j.drugalcdep.2012.10.026. - DOI - PMC - PubMed
-
- Banks Matthew L, Blough Bruce E, Negus S Stevens. Effects of 14-day treatment with the schedule III anorectic phendimetrazine on choice between cocaine and food in rhesus monkeys. Drug Alcohol Depend. 2013;131(3):204–213. doi: http://dx.doi.org/10.1016/j.drugalcdep.2013.05.005. - DOI - PMC - PubMed
-
- Cachope Roger, Mateo Yolanda, Mathur Brian N, Irving James, Wang Hui-Ling, Morales Marisela, Cheer Joseph F. Selective Activation of Cholinergic Interneurons Enhances Accumbal Phasic Dopamine Release: Setting the Tone for Reward Processing. Cell Reports. 2012;2(1):33–41. doi: http://dx.doi.org/10.1016/j.celrep.2012.05.011. - DOI - PMC - PubMed
-
- Cunningham CS, Polston JE, Jany JR, Segert IL, Miller DK. Interaction of lobeline and nicotinic receptor ligands with the discriminative stimulus properties of cocaine and amphetamine. Drug Alcohol Depend. 2006;84(3):211–222. S0376- 8716(06)00039-1. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
